Charles Q. Meng
AtheroGenics
Inc., 8995 Westside Parkway
Alpharetta
USA
Name/email consistency: high
- Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases. Meng, C.Q., Ni, L., Worsencroft, K.J., Ye, Z., Weingarten, M.D., Simpson, J.E., Skudlarek, J.W., Marino, E.M., Suen, K.L., Kunsch, C., Souder, A., Howard, R.B., Sundell, C.L., Wasserman, M.A., Sikorski, J.A. J. Med. Chem. (2007)
- Atherosclerosis is an inflammatory disorder after all. Meng, C.Q. Curr. Top. Med. Chem (2006)
- Inflammation in atherosclerosis: new opportunities for drug discovery. Meng, C.Q. Mini. Rev. Med. Chem (2005)
- Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression. Meng, C.Q., Zheng, X.S., Ni, L., Ye, Z., Simpson, J.E., Worsencroft, K.J., Hotema, M.R., Weingarten, M.D., Skudlarek, J.W., Gilmore, J.M., Hoong, L.K., Hill, R.R., Marino, E.M., Suen, K.L., Kunsch, C., Wasserman, M.A., Sikorski, J.A. Bioorg. Med. Chem. Lett. (2004)
- Discovery of novel phenolic antioxidants as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases. Meng, C.Q., Somers, P.K., Hoong, L.K., Zheng, X.S., Ye, Z., Worsencroft, K.J., Simpson, J.E., Hotema, M.R., Weingarten, M.D., MacDOnald, M.L., Hill, R.R., Marino, E.M., Suen, K.L., Luchoomun, J., Kunsch, C., Landers, L.K., Stefanopoulos, D., Howard, R.B., Sundell, C.L., Saxena, U., Wasserman, M.A., Sikorski, J.A. J. Med. Chem. (2004)
- BO-653. Chugai. Meng, C.Q. Curr. Opin. Investig. Drugs (2003)
- HDL Cholesterol 2003--Fourth Annual International Conference. Metabolic pathways and drug targets. 2-4 March 2003, Cambridge, MA, USA. Meng, C.Q. IDrugs (2003)
- Ezetimibe. Schering-Plough. Meng, C.Q. Curr. Opin. Investig. Drugs (2002)
- Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis. Meng, C.Q., Somers, P.K., Rachita, C.L., Holt, L.A., Hoong, L.K., Zheng, X.S., Simpson, J.E., Hill, R.R., Olliff, L.K., Kunsch, C., Sundell, C.L., Parthasarathy, S., Saxena, U., Sikorski, J.A., Wasserman, M.A. Bioorg. Med. Chem. Lett. (2002)
- Nitrobenzene compounds inhibit expression of VCAM-1. Meng, C.Q., Zheng, X.S., Holt, L.A., Hoong, L.K., Somers, P.K., Hill, R.R., Saxena, U. Bioorg. Med. Chem. Lett. (2001)
- Ezetimibe (Schering-Plough). Meng, C.Q. Curr. Opin. Investig. Drugs (2001)
- Restenosis drug discovery--a formidable task. Meng, C.Q. Curr. Opin. Investig. Drugs (2001)
- 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine. Meng, C.Q., Rakhit, S., Lee, D.K., Kamboj, R., McCallum, K.L., Mazzocco, L., Dyne, K., Slassi, A. Bioorg. Med. Chem. Lett. (2000)